The FDA has accepted Moderna’s revised influenza vaccine filing days after controversially refusing to review the ori...
The FDA accepted Moderna's revised influenza vaccine filing after initially refusing to review the original submission. The acceptance puts Moderna's mRNA flu vaccine on track for potential approval in time for the 2026–27 flu season.
Why it mattersFDA acceptance of Moderna's revised influenza vaccine filing accelerates procurement planning for 2026–27 flu season.